Simplex Trading’s Humacyte HUMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$35.1K Buy
57,900
+5,000
+9% +$5.2K ﹤0.01% 6227
2025
Q4
$50.8K Buy
52,900
+30,700
+138% +$43.5K ﹤0.01% 5641
2025
Q3
$38K Sell
22,200
-10,700
-33% -$21K ﹤0.01% 6724
2025
Q2
$68K Sell
32,900
-7,300
-18% -$14K ﹤0.01% 5606
2025
Q1
$68K Sell
40,200
-303,500
-88% -$1.14M ﹤0.01% 5477
2024
Q4
$1.74M Buy
343,700
+117,200
+52% +$580K ﹤0.01% 2324
2024
Q3
$1.23M Buy
226,500
+135,300
+148% +$892K ﹤0.01% 2719
2024
Q2
$437K Buy
91,200
+46,900
+106% +$244K ﹤0.01% 3806
2024
Q1
$137K Sell
44,300
-11,900
-21% -$40K ﹤0.01% 5264
2023
Q4
$159K Buy
56,200
+49,200
+703% +$126K ﹤0.01% 4903
2023
Q3
$20K Buy
7,000
+2,200
+46% +$7.28K ﹤0.01% 6619
2023
Q2
$13K Sell
4,800
-2,800
-37% -$10.1K ﹤0.01% 7163
2023
Q1
$23K Buy
7,600
+5,900
+347% +$16.8K ﹤0.01% 6776
2022
Q4
$3K Sell
1,700
-20,200
-92% -$61.3K ﹤0.01% 8368
2022
Q3
$71K Buy
21,900
+1,600
+8% +$6.14K ﹤0.01% 5977
2022
Q2
$65K Sell
20,300
-14,000
-41% -$77.8K ﹤0.01% 6148
2022
Q1
$242K Buy
34,300
+12,700
+59% +$73.9K ﹤0.01% 4878
2021
Q4
$156K Buy
+21,600
New +$214K ﹤0.01% 5541

Other funds holding HUMA

Simplex Trading's HUMA Position: Q1 2025 in Review

Simplex Trading sold out of Humacyte (HUMA) in Q1 2025, closing a stake of 96,175 shares — an estimated $361K sold.

Simplex Trading first reported a position in HUMA in Q4 2021 and held it in 11 quarters. The position peaked at $711K in Q3 2024. 168 funds tracked by Wall St. Rank hold HUMA as of Q1 2025.

  • Simplex Trading reported no remaining Humacyte position as of Q1 2025 after selling out during the quarter.
  • Simplex Trading sold 96,175 Humacyte shares in Q1 2025, an estimated $361K.
  • Simplex Trading first reported a position in Humacyte in Q4 2021 and held it in 11 quarters.
  • Simplex Trading's Humacyte position peaked at $711K in Q3 2024.
  • 168 funds tracked by Wall St. Rank held Humacyte as of Q1 2025.

Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.